🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 05548N107
- Market Cap
- Small Cap · $211 Million
- IPO
- 9/19/2013 · $15.00/share
- Previous Symbol
- BIND (changed 8/1/2016)
Business: BIND Therapeutics, Inc. is a clinical-stage nanomedicine platform company developing Accurins, its novel targeted therapeutics. BIND intends to leverage its Medicinal Nanoengineering platform to develop a pipeline of Accurins, initially in oncology, as well as Accurins in collaboration with biopharmaceutical companies. In December 2013, BIND Therapeutics was added as a member of the Russell 2000, Russell 3000, Russell Global and Russell Microcap Indexes.
Company Contact
- CEO
- Scott Minick
- CFO
- Andrew Hirsch
- Headquarters
- 325 Vassar Street, Cambridge, MA 02139
- Phone
- 617-491-3400
- Fax
- 617-491-0351
- Investor Relations
- Paul Cox, Stern Investor Relations · 212-362-1200 · BIND@sternir.com